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Letters to the Editor 1289AP window. The baby was born at term in good condition, and
postnatal echocardiography was consistent with prenatal diagnosis.
Computed tomography angiography (Fig. 2) was consistent with the
remnant of a persistent 5th arch artery, and successful surgery was
performed.
The features in case 1 suggested the likely diagnosis of persistent 5th
arch rather than an AP window because the AP communicating artery
was connecting distal to the origin of the pulmonary arteries. In an AP
window, this would be positioned along the pulmonary trunk and
bifurcation of the pulmonary arteries. A high AP window may extend
to the origin of the right pulmonary artery, but the window is not in the
form of a channel with a length resembling a vessel. Moreover, the
characteristic wall structure of the arterial duct identified at surgery in
our case supported the likely origin of the vessel as a remnant of the
fifth arch artery. For the second case, the differentiating point from an
arterial duct was the location of the communicating artery connecting
the aorta proximal to the origin of the head and neck vessels; an arterial
duct would communicate distal to the arch arteries.
Both fetuses reported here likely had vascular channels that
represented remnants of a 5th aortic arch artery. Failure to diagnose
aortic interruption with persistence of the 5th arch arterial channel
in our first case resulted in prolonged surgery and subsequent
demise. Lessons learned from this case led to appropriate consid-
erations in the second fetus, confirmation by postnatal imaging, and
appropriate surgery that resulted in a good outcome.
Although postnatal reports of a persistent 5th arch artery exist
(2), we have demonstrated that fetal diagnosis is possible and that
additional imaging, such as computed tomography angiography, is
useful to confirm prenatal diagnosis after birth and aid its successful
surgical management.
Victoria Jowett, MB BS,* Michael Rubens, MB BS,
Siew Yen Ho, PhD, Hideki Uemura, MD,
Figure 2. Postnatal CT Angiogram of Case 2
This shows the 5th arch artery connecting the pulmonary trunk and aorta.
The communication with the aorta is proximal to the origin of the head and
neck vessels. CT  computed tomography.Helena M. Gardiner, PhD, MD i*Reproductive Biology, Division of Cancer, Imperial College London
Du Cane Road, London W12 OHS, United Kingdom. E-mail:
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Repeat Routine Differential
Pulmonary Blood Flow
Measurements in Congenital Heart
Disease by MR
Interstudy Variability and Benchmark of a
Clinically Relevant Change
Phase-velocity magnetic resonance (PV-MR) quantifies differential
pulmonary blood flow as accurately as the previous gold standard lung
perfusion scintigraphy in patients with a single pulmonary blood source
supplied by a subpulmonary ventricle (1–3). Therefore, in routine
clinical practice, PV-MR has taken on the role of quantifying differ-
ential pulmonary blood flow in congenital heart disease (4). However,
he interstudy variability and a benchmark of a clinically relevant
hange of repeat routine differential pulmonary blood flow measure-
ents in congenital heart disease using PV-MR are still unknown.
To test the interstudy variability, we studied 80 consecutive
outine clinical cases without intervention or pathological event of
he pulmonary branch arteries between 2 consecutive PV-MR
easurements (control group). Therefore, in this group, no change
f the measured differential pulmonary blood flow ratio was to be
xpected. This group consisted of 56 cases with repaired tetralogy of
allot, pulmonary atresia, or truncus arteriosus communis, 7 cases
ith atrial switch operation, 6 cases with arterial switch operation, 5 cases
ithRoss operation, and 6 caseswith other congenital heart defects.Mean
ge was 23.2 9.8 years at the time of the first measurement.Mean time
etween the 2 measurements was 1.2  0.6 years.
To establish a benchmark of a clinically relevant change of repeat
outine differential pulmonary blood flow measurements using PV-
R, we studied 13 consecutive routine clinical cases with an explicit
nilateral intervention or morphological change to 1 of the pulmonary
ranch arteries between 2 PV-MR measurements (intervention
roup). Therefore, in this group, a clear change of the measured
ifferential pulmonary blood flow ratio was to be expected. It is
mportant to note that in our center, PV-MR measurements are not
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Letters to the Editor1290used to decide whether a pulmonary branch artery needs treatment.
This group consisted of 11 cases with stent implantation or balloon
dilation of 1 of the pulmonary arteries and 2 cases of a post-operative
hematoma compressing the left pulmonary artery. Mean age was
21.9  8.3 years at the time of the first measurement. Mean time
etween the 2 measurements was 0.8  1.0 years.
In each of the measurements, we evaluated net flow volumes in
the right and left pulmonary arteries. The representative entity for
the differential pulmonary blood flow ratio was defined as percent
right pulmonary blood flow as previously described (1) and calcu-
lated using the following equation: percent right pulmonary blood
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Figure 1. Bland-Altman Analysis of Control Group
Mean difference between 2 consecutive percent right pulmonary blood ﬂow meas
50
40
30
20
10
0
-10
-20
-30
-40
-50
0
Mean Percent R
Inte
(grey zone depicts 95% li
D
iff
er
en
ce
 B
et
w
ee
n 
Fi
rs
t a
nd
 S
ec
on
d 
Pe
rc
en
t
R
ig
ht
 P
ul
m
on
ar
y 
Bl
oo
d 
Fl
ow
 (%
)
10 10 30
Figure 2. Bland-Altman Analysis of Intervention Group
Mean difference between 2 consecutive percent right pulmonary blood ﬂow m
Note: all measurements of the intervention group lie outside of the 95% limits of aow  100  [RPA net flow volume/(RPA net flow volume 
PA net flow volume)], where RPA and LPA are the right and left
ulmonary arteries, respectively.
Bland-Altman analysis determined the 95% limits of agreement
etween 2 consecutive PV-MR measurements (5). The difference
etween 2 consecutive PV-MR measurements was calculated by
ubtracting percent right pulmonary blood flow at the first time
oint from the second time point.
In the control group, the mean difference between the first and
econd measurements of percent right pulmonary blood flow was2%
ith 95% limits of agreement of 8% and11% (Fig. 1). In contrast to
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Letters to the Editor 1291this, in the intervention group, the differences between the 2 measure-
ments of percent right pulmonary blood flow were all located outside
of the 95% limits of agreement of the control group (Fig. 2).
Furthermore, in the intervention group, the absolute change of
ercent right pulmonary blood flow was significant at 22  8%
(p  0.001), consistent with the side on which the procedure was
erformed and the absolute change of the pressure gradient of 22
7 mm Hg (p  0.029).
The results of this study show that consecutive routine clinical
differential pulmonary blood flow measurements in congenital heart
disease cases without intervention of the pulmonary branch arteries
are highly reproducible by PV-MR, with an interstudy variability of
up to about 10% (control group, Fig. 1). Moreover, we can use the
results of our study to establish a benchmark of a clinically relevant
change of repeat routine differential pulmonary blood flow mea-
surements in congenital heart disease using PV-MR in a “real-life”
setting (intervention group, Fig. 2). The 95% limits of agreement of
repeat routine clinical measurements of percent right pulmonary
blood flow by PV-MR of cases without intervention or pathological
event of the pulmonary branch arteries (control group) were 8% and
11%. In contrast to this, all measured values in the intervention
group were outside of these 95% limits of agreement of the control
group. Consequently, we suggest that by using the deviations of 8%
and 11% as benchmarks for measurement reproducibility, pa-
tients with a clinically relevant change (as assessed by the interven-
tionist) of their differential pulmonary blood flow ratio will correctly
be recognized in 100% of the cases. Moreover, patients withouthange of their differential pulmonary blood flow ratio will correctly
e recognized in 95% of the cases.
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